Xilio Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XLO and other ETFs, options, and stocks.About XLO
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer.
CEORené Russo
CEORené Russo
Employees64
Employees64
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2015
Founded2015
Employees64
Employees64
XLO Key Statistics
Market cap38.48M
Market cap38.48M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume538.98K
Average volume538.98K
High today$0.7756
High today$0.7756
Low today$0.7061
Low today$0.7061
Open price$0.718
Open price$0.718
Volume474.60K
Volume474.60K
52 Week high$1.70
52 Week high$1.70
52 Week low$0.615
52 Week low$0.615
Stock Snapshot
Xilio Therapeutics(XLO) stock is priced at $0.73, giving the company a market capitalization of 38.48M. It carries a P/E multiple of -1.11.
As of 2025-12-10, Xilio Therapeutics(XLO) stock has fluctuated between $0.71 and $0.78. The current price stands at $0.73, placing the stock +3.7% above today's low and -5.6% off the high.
Xilio Therapeutics(XLO) shares are trading with a volume of 474.6K, against a daily average of 538.98K.
During the past year, Xilio Therapeutics(XLO) stock moved between $0.62 at its lowest and $1.70 at its peak.
During the past year, Xilio Therapeutics(XLO) stock moved between $0.62 at its lowest and $1.70 at its peak.
People also own
Based on the portfolios of people who own XLO. This list is generated using Robinhood data, and it’s not a recommendation.